| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/16/1998 | CN1193350A Antigen non-specific glycosylation inhibiting factor derivatives |
| 09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
| 09/16/1998 | CN1193348A Enzymes and micro-organisms with amidase activity for hydrolysing polyamides |
| 09/16/1998 | CN1193347A Enzymes and microorganisms having amidase activity for hydrolysing polyamides |
| 09/16/1998 | CN1193346A Modified enzyme with lipolytic activity |
| 09/16/1998 | CN1193345A Neural transplantation using pluripotent neuroepithelial cells |
| 09/16/1998 | CN1193316A New cationic and polycationic amphiphiles, reagent containing same and their use |
| 09/16/1998 | CN1193280A Control of CD44 gene expression for therapeutic use |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1193253A Method for transforming orchidaceous plant using agrobacterium |
| 09/16/1998 | CN1193047A C3 plants expressing photosynthetic enzyme of C4 plants |
| 09/16/1998 | CN1193046A In vitro transcription processes for screening natural products and other chemical substances |
| 09/15/1998 | US5808059 Matrix-supported sapphyrins |
| 09/15/1998 | US5808043 Composition for stabilization of labelled nucleoside triphosphates and methods for using same |
| 09/15/1998 | US5808041 Nucleic acid purification using silica gel and glass particles |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5808034 Genetic engineering |
| 09/15/1998 | US5808033 Family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/15/1998 | US5808032 Anti-HBS antibody genes and expression plasmids therefor |
| 09/15/1998 | US5808031 Human gene associated with arrest of cell growth and dna damage induction; diagnosis and treatment of cancer |
| 09/15/1998 | US5808030 Polypeptide |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808028 Molecular clone of a P58 receptor protein and uses thereof |
| 09/15/1998 | US5808027 N-2 substituted purines in oligonucleotides |
| 09/15/1998 | US5808025 Polypeptide |
| 09/15/1998 | US5808024 Nucleic acids encoding high molecular weight major outer membrane protein of moraxella |
| 09/15/1998 | US5808012 Protein-enriched thermoplastics |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808006 Refolding of polypeptides like recombinant insulin-like growth factor IGF-I |
| 09/15/1998 | US5808001 Human ice homolog antibodies and compositions thereof |
| 09/15/1998 | US5807999 Analyzing |
| 09/15/1998 | US5807998 Modified urf13-T protein |
| 09/15/1998 | US5807996 Fused polypeptides comprising interleukin-4 polypeptide fragments |
| 09/15/1998 | US5807995 Diagnosis and treatment of cancer |
| 09/15/1998 | US5807991 Human interleukin-5 receptor |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807980 Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex |
| 09/15/1998 | US5807893 Plant thioesterases and use for modification of fatty acid composition in plant seed oils |
| 09/15/1998 | US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807746 Administering signal peptide complex; antisense therapy, gene transfer |
| 09/15/1998 | US5807743 Nucleic acid |
| 09/15/1998 | US5807742 Amplification copies of dna sequences |
| 09/15/1998 | US5807740 Regulators of UCP2 gene expression |
| 09/15/1998 | US5807738 Human fetoprotein |
| 09/15/1998 | US5807735 Solvent-resistant microorganisms |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807731 Antitumor |
| 09/15/1998 | US5807730 Genetic engineering |
| 09/15/1998 | US5807729 Isolated nucleic acid |
| 09/15/1998 | US5807726 Nucleic acids encoding dog gastric lipase and their use for the production of polypeptides |
| 09/15/1998 | US5807725 Long-chain prenyl diphosphate synthase |
| 09/15/1998 | US5807723 Homologously recombinant slow growing mycobacteria and uses therefor |
| 09/15/1998 | US5807718 Ribonucleic acid(rna) cleavage; dephosporization; genetic engineering; catalysis |
| 09/15/1998 | US5807714 Method of production of antigen-specific glycosylation inhibiting factor |
| 09/15/1998 | US5807712 Genetic engineered protein |
| 09/15/1998 | US5807711 Parenchymal hepatocyte growth factors |
| 09/15/1998 | US5807710 Nucleic acids encoding stable mutants of D-N-α-carbamoylase |
| 09/15/1998 | US5807709 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807708 Conservin nucleic acid molecules and compositions |
| 09/15/1998 | US5807707 High efficiency translation of mRNA molecules |
| 09/15/1998 | US5807706 Genetic engineering |
| 09/15/1998 | US5807705 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, DNA encoding same and uses thereof |
| 09/15/1998 | US5807703 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807702 Genetic engineering |
| 09/15/1998 | US5807698 Human cyclin E |
| 09/15/1998 | US5807692 P21WAF1 derivatives and diagnostic methods |
| 09/15/1998 | US5807691 Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/15/1998 | US5807688 Catalytic antibodies for carbamate activation by a non-spontaneous reaction mechanism |
| 09/15/1998 | US5807685 Lyme disease |
| 09/15/1998 | US5807680 Genetic engineering; cloning inserts; transformation, transcription; polymerase chain reactions; drug screening; medical diagnosis |
| 09/15/1998 | US5807678 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia |
| 09/15/1998 | US5807677 Method for direct identification of few nucleic acid strands |
| 09/15/1998 | US5807676 Amplification |
| 09/15/1998 | US5807674 Diagnostic assays and kits for RNA using RNA binary probes and a protein that is an RNA-directed RNA ligase |
| 09/15/1998 | US5807673 Probe for diagnosing infectious disease |
| 09/15/1998 | US5807672 Dna sequences, diagnosing tuberculosis |
| 09/15/1998 | US5807671 Method of screening for genetic predisposition to anticholinesterase therapy |
| 09/15/1998 | US5807670 Oligonucleotide primers; genetic engineering |
| 09/15/1998 | US5807557 Vaccine |
| 09/15/1998 | US5807550 Antibodies specifically recognizing somatotropin binding proteins |
| 09/15/1998 | US5807548 Method of treating cancer using a chimera antibody |
| 09/15/1998 | US5807522 Tapping capillary dispenser on support with impulse to break meniscus; gene expression studies to diagnose disease |
| 09/15/1998 | CA1340045C Recombinant escherichia coli that produces bricella o-chain polysaccharide |
| 09/14/1998 | CA2231917A1 Promoter of the cdc25b gene, its preparation and use |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2199989A1 Expression of a foamy virus envelope protein |
| 09/12/1998 | CA2230296A1 Processes for purifying synthetic oligonucleotides |
| 09/12/1998 | CA2219964A1 Polypeptide capable of binding interleukin-18 and uses therof |
| 09/11/1998 | WO1998039661A1 Method for identifying hormonally modulated genes |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039487A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | WO1998039486A1 Methods and compositions for the treatment of injury to the central nervous system |
| 09/11/1998 | WO1998039484A1 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 09/11/1998 | WO1998039483A1 Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| 09/11/1998 | WO1998039482A1 Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |